Drug Transport to Brain with Targeted Liposomes
AUTOR(ES)
Schnyder, Anita
FONTE
The American Society for Experimental NeuroTherapeutics
RESUMO
Summary: Antibody-conjugated liposomes or immunoliposomes are particulate drug carriers that can be used to direct encapsulated drug molecules to diseased tissues or organs. The present review discusses examples of successful applications of this technology to achieve drug transport across the blood-brain barrier. In addition, information will be provided on practical aspects such as phospholipid compositions of liposomes, antibody coupling technologies, large-scale production of liposomes, and obstacles related to drug loading of the carrier. Prospects of future uses of immunoliposome-based drug delivery systems such as gene therapy of the brain and clinical trials are discussed.
ACESSO AO ARTIGO
http://www.pubmedcentral.nih.gov/articlerender.fcgi?artid=539328Documentos Relacionados
- Drug Transport to Brain with Targeted Nanoparticles
- How to Measure Drug Transport across the Blood-Brain Barrier
- Gene transfer from targeted liposomes to specific lymphoid cells by electroporation.
- Antibody-targeted liposomes containing oligodeoxyribonucleotides complementary to viral RNA selectively inhibit viral replication.
- Blood-brain barrier and new approaches to brain drug delivery.
